REPORT ID 6573

EMEA (Europe, Middle East and Africa) Androgens Market Report 2017

Publish Date
26-Dec-17
Pages
100
Format
Electronic (PDF)

In this report, the EMEA Androgens market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (Units), revenue (Million USD), market share and growth rate of Androgens for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Androgens market competition by top manufacturers/players, with Androgens sales volume (Units), price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Pfizer
    Sanofi-Aventis
    Abbott
    Dendreon
    AstraZeneca
    Anabolics
    ABBVIE
    Wuhan Nuohui Pharmaceutical And Chwmical

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Solution
    Implant
    Capsule
    Kit
    Tablet
    Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Anemias
    Delayed Growth Spurt
    Lichen Sclerosus
    Microphallus
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Androgens Market Report 2017
1 Androgens Overview
    1.1 Product Overview and Scope of Androgens
    1.2 Classification of Androgens
        1.2.1 EMEA Androgens Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Androgens Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Solution
        1.2.4 Implant
        1.2.5 Capsule
        1.2.6 Kit
        1.2.7 Tablet
        1.2.8 Other
    1.3 EMEA Androgens Market by Application/End Users
        1.3.1 EMEA Androgens Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Anemias
        1.3.3 Delayed Growth Spurt
        1.3.4 Lichen Sclerosus
        1.3.5 Microphallus
        1.3.6 Other
    1.4 EMEA Androgens Market by Region
        1.4.1 EMEA Androgens Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Androgens (2012-2022)
        1.5.1 EMEA Androgens Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Androgens Revenue and Growth Rate (2012-2022)

2 EMEA Androgens Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Androgens Market Competition by Players/Manufacturers
        2.1.1 EMEA Androgens Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Androgens Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Androgens Sale Price by Players (2012-2017)
    2.2 EMEA Androgens (Volume and Value) by Type/Product Category
        2.2.1 EMEA Androgens Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Androgens Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Androgens Sale Price by Type (2012-2017)
    2.3 EMEA Androgens (Volume) by Application
    2.4 EMEA Androgens (Volume and Value) by Region
        2.4.1 EMEA Androgens Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Androgens Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Androgens Sales Price by Region (2012-2017)

3 Europe Androgens (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Androgens Sales and Value (2012-2017)
        3.1.1 Europe Androgens Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Androgens Revenue and Growth Rate (2012-2017)
    3.2 Europe Androgens Sales and Market Share by Type
    3.3 Europe Androgens Sales and Market Share by Application
    3.4 Europe Androgens Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Androgens Sales Volume by Countries (2012-2017)
        3.4.2 Europe Androgens Revenue by Countries (2012-2017)
        3.4.3 Germany Androgens Sales and Growth Rate (2012-2017)
        3.4.4 France Androgens Sales and Growth Rate (2012-2017)
        3.4.5 UK Androgens Sales and Growth Rate (2012-2017)
        3.4.6 Russia Androgens Sales and Growth Rate (2012-2017)
        3.4.7 Italy Androgens Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Androgens Sales and Growth Rate (2012-2017)

4 Middle East Androgens (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Androgens Sales and Value (2012-2017)
        4.1.1 Middle East Androgens Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Androgens Revenue and Growth Rate (2012-2017)
    4.2 Middle East Androgens Sales and Market Share by Type
    4.3 Middle East Androgens Sales and Market Share by Application
    4.4 Middle East Androgens Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Androgens Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Androgens Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Androgens Sales and Growth Rate (2012-2017)
        4.4.4 Israel Androgens Sales and Growth Rate (2012-2017)
        4.4.5 UAE Androgens Sales and Growth Rate (2012-2017)
        4.4.6 Iran Androgens Sales and Growth Rate (2012-2017)

5 Africa Androgens (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Androgens Sales and Value (2012-2017)
        5.1.1 Africa Androgens Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Androgens Revenue and Growth Rate (2012-2017)
    5.2 Africa Androgens Sales and Market Share by Type
    5.3 Africa Androgens Sales and Market Share by Application
    5.4 Africa Androgens Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Androgens Sales Volume by Countries (2012-2017)
        5.4.2 Africa Androgens Revenue by Countries (2012-2017)
        5.4.3 South Africa Androgens Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Androgens Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Androgens Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Androgens Sales and Growth Rate (2012-2017)

6 EMEA Androgens Manufacturers/Players Profiles and Sales Data
    6.1 Pfizer
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Androgens Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Pfizer Androgens Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Sanofi-Aventis
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Androgens Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Sanofi-Aventis Androgens Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Abbott
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Androgens Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Abbott Androgens Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Dendreon
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Androgens Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Dendreon Androgens Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 AstraZeneca
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Androgens Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 AstraZeneca Androgens Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Anabolics
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Androgens Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Anabolics Androgens Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 ABBVIE
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Androgens Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 ABBVIE Androgens Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Wuhan Nuohui Pharmaceutical And Chwmical
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Androgens Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Wuhan Nuohui Pharmaceutical And Chwmical Androgens Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview

7 Androgens Manufacturing Cost Analysis
    7.1 Androgens Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Androgens

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Androgens Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Androgens Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Androgens Market Forecast (2017-2022)
    11.1 EMEA Androgens Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Androgens Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Androgens Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Androgens Price and Trend Forecast (2017-2022)
    11.2 EMEA Androgens Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Androgens Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Androgens Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Androgens Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Androgens Sales Forecast by Type (2017-2022)
    11.7 EMEA Androgens Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer